Laboratório de Pesquisas Clínicas e Experimentais em Biologia Vascular, Centro Biomédico, Universidade do Estado do Rio de Janeiro, RJ, Brazil.
Microvasc Res. 2013 Nov;90:121-7. doi: 10.1016/j.mvr.2013.08.001. Epub 2013 Aug 12.
Arterioles display cyclic variations in diameter, termed vasomotion initiated by smooth muscle cells (SMCs), but the endothelium should also be evaluated due to its modulatory role on vessel tone. Since nitric oxide (NO) and prostacyclin (PGI2) regulate SMC tone and activate K(+) currents, we have investigated their role on vasomotion, by observing effects of topical application of N(ω)-nitro-l-arginine (L-NA, NO synthesis inhibitor), glibenclamide (KATP channel inhibitor), sodium nitroprusside (SNP, NO donor), iloprost (PGI2 analogue) and methylene blue (MB, cGMP production inhibitor) on the cheek pouch preparation of anesthetized male hamsters. L-NA (10(-10)-10(-6)M) induced vasoconstriction, reduction and abolition of vasomotion. MB (10(-7) to 10(-5)M) reduced mean arteriolar diameter with no changes on vasomotion. In the presence of 10(-6)M of MB, addition of 10(-6)L-NA totally abolished vasomotion without further constriction. Glibenclamide (10(-6)M) in the presence of L-NA at equimolar concentration restored both vasomotion frequency and amplitude. This effect was not observed in the presence of TEA 5mM. SNP (10(-10)-10(-6)M) induced a dose-dependent increase of arteriolar diameter and decreased vasomotion. Iloprost (10(-12)-10(-6)M) induced a concentration dependent increase of arteriolar diameter, reduced vasomotion frequency, but in lower concentrations (10(-12)-10(-10)M) increased its amplitude and in higher concentrations (10(-9)-10(-6)M) decreased it. SNP and iloprost inhibited vasomotion at 10(-7)M; however, at this concentration SNP and iloprost induced an increment of 35% and 50% of the initial arteriolar diameter, respectively. In the presence of L-NA (10(-6)M), vasomotion was restored by SNP at 10(-10)M and iloprost 10(-12)M, which corresponded to 80% of the initial diameter value. Around the initial (control) arteriolar diameter value, vasomotion presented its highest frequencies and amplitudes. Cessation of vasomotion occurred with L-NA (10(-6)M) in the presence of SNP (10(-6)M) and iloprost (10(-7)M) when arteriolar diameter reached 150% and 120% of its initial value, respectively. In conclusion, the present study strongly suggests that vasomotion (1) is not solely related to vascular tone, (2) needs an interplay between vascular tone and membrane currents and (3) could be modulated by NO (but not cGMP) and KATP channels. In addition, our results point to the existence of dissociation between vasomotion frequency and amplitude.
小动脉表现出直径的周期性变化,称为由平滑肌细胞 (SMC) 引发的血管舒缩运动,但由于内皮细胞对血管张力具有调节作用,因此也应该对其进行评估。由于一氧化氮 (NO) 和前列环素 (PGI2) 调节 SMC 张力并激活 K(+)电流,我们通过观察局部应用 N(ω)-硝基-l-精氨酸 (L-NA,NO 合成抑制剂)、格列本脲 (KATP 通道抑制剂)、硝普钠 (NO 供体)、伊洛前列素 (PGI2 类似物) 和亚甲蓝 (MB,cGMP 产生抑制剂)对麻醉雄性仓鼠颊囊制剂的影响,研究了它们在血管舒缩运动中的作用。L-NA (10(-10)-10(-6)M) 诱导血管收缩、减少和消除血管舒缩运动。MB (10(-7) 至 10(-5)M) 减小平均小动脉直径,但对血管舒缩运动没有影响。在 10(-6)M 的 MB 存在下,添加 10(-6)L-NA 完全消除了血管舒缩运动,而没有进一步收缩。在等摩尔浓度的 L-NA 存在下,格列本脲 (10(-6)M) 恢复了血管舒缩运动的频率和幅度。在存在 5mM TEA 的情况下,没有观察到这种效果。SNP (10(-10)-10(-6)M) 诱导小动脉直径的剂量依赖性增加,并降低血管舒缩运动。伊洛前列素 (10(-12)-10(-6)M) 诱导小动脉直径的浓度依赖性增加,降低血管舒缩运动的频率,但在较低浓度 (10(-12)-10(-10)M) 时增加其幅度,在较高浓度 (10(-9)-10(-6)M) 时降低其幅度。SNP 和伊洛前列素在 10(-7)M 时抑制血管舒缩运动;然而,在该浓度下,SNP 和伊洛前列素分别诱导初始小动脉直径增加 35%和 50%。在 L-NA (10(-6)M) 的存在下,SNP 在 10(-10)M 和伊洛前列素 10(-12)M 下恢复了血管舒缩运动,这相当于初始直径值的 80%。在初始 (对照) 小动脉直径值附近,血管舒缩运动呈现出最高的频率和幅度。当小动脉直径达到初始直径的 150%和 120%时,分别用 L-NA (10(-6)M) 和 SNP (10(-6)M) 和伊洛前列素 (10(-7)M) 会导致血管舒缩运动停止。总之,本研究强烈表明,血管舒缩运动 (1) 不仅与血管张力有关, (2) 需要血管张力和膜电流之间的相互作用, (3) 可以通过 NO (但不是 cGMP) 和 KATP 通道来调节。此外,我们的结果表明,血管舒缩运动的频率和幅度之间存在分离。